Abbott Laboratories (ABT) Stock Analysis

BUY

ABT Equity Research — BUY — June 2026

Rating date

Jun 25, 2026

46 days ago

Desk view

BUY

5D move

Awaiting market data

Peer rank

85p

Investment card · ABT

I have all the data I need. Here's the analysis.

Desk rating

BUY

Tactical BUY · 12M BUY

Horizon

Short to medium term

Confidence

High

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Bias

BUY

Catalysts

  • Bear trend intact, but showing signs of life. The long-term structure remains bearish (price far below declining 200-day SMA), yet the short-term momentum and price action have improved markedly from the late-May lows.
  • Bullish MACD crossover is the strongest technical signal. The MACD turning positive at +0.38 after months in negative territory is a meaningful shift in momentum dynamics.
  • RSI has headroom. At 61, RSI is not yet approaching overbought (70), suggesting the bounce could extend further before momentum becomes stretched.

Risks

  • Event-driven repricing risk if expectations diverge from incoming evidence.

Market chart

Price context alongside the research narrative.

ABT Research Note

Full desk note for Jun 25, 2026. Use tabs for catalysts, valuation and risks, or open the full note.

31 min read

WebserviceX · Agentic Research Desk

ABT Equity Research Note

Published Jun 25, 2026 · Desk view BUY · Generated 2026-06-26T07:32:11Z · Maintained by Walter Vijayakumar · Methodology · Track record

ABT Stock Rating Summary

ABT bias

BUY

Horizon

Short to medium term

ABT key risk

Event-driven repricing risk if expectations diverge from incoming evidence.

ABT catalyst watch

Bear trend intact, but showing signs of life. The long-term structure remains bearish (price far below declining 200-day SMA), yet the short-term momentum and price action have improved markedly from the late-May lows.

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Confidence

High

How the call aged · 5D

Awaiting market dataPeer 85p
Expand

Grading rule: BUY/OVERWEIGHT scores Correct when forward return > 0; UNDERWEIGHT/SELL when < 0; HOLD is Neutral. Window uses 5 US trading sessions after the rating entry close vs benchmark SPY. Scorecard computed 2026-06-26T08:37:04.699783+00:00.

5D move

2026-06-25 → awaiting

Outcome

Awaiting market data

5D trend

+5.36%

Vol (20D ann.)

+28.12%

vs SPY: +6.00%

Close 93.24 (USD, vendor closes)

Batch scorecard · 2026-06-25 · ABT

Publish QC

passed
Expand

Pipeline fingerprint 2f45a102687f75c0

Trace f66d55ad

No QC issues recorded.